Semaglutide vs Tirzepatide: The Cheaper Effective GLP-1

Both drugs work. The real question is value: which one buys you the most weight loss per dollar for your goals? Semaglutide is usually the cheaper molecule; tirzepatide usually loses more weight. Whether the premium is worth it depends on how far you need to go — and how flat the price is.

What the trials actually show

In the STEP-1 trial, once-weekly semaglutide produced roughly 15% average body-weight loss over 68 weeks¹. In SURMOUNT-1, tirzepatide reached up to about 21% at its highest dose². And in a head-to-head diabetes trial, SURPASS-2, tirzepatide beat semaglutide on weight and A1C reduction³. So on raw effect, tirzepatide has the higher ceiling. That is the effectiveness half of "cheaper effective."

The price half

Effect isn't free. Across the cash-pay programs we track, compounded semaglutide typically starts lower than compounded tirzepatide from the same provider — per each provider's published pricing (last reviewed 2026). A program might list semaglutide near $99-$149 flat and tirzepatide $150-$399. That spread is the premium you pay for tirzepatide's higher ceiling. Sometimes it's small (a tight $99/$125 spread is genuinely worth it); sometimes it's large enough to reconsider. See the full spread for yourself on our cheapest semaglutide ladder and our cheapest tirzepatide ladder. For a concrete version of that spread inside one provider, $150 semaglutide against $199 tirzepatide on a single published table is a $49 monthly premium — $294 across six months — for the higher-ceiling molecule.

Effect per dollar: how to decide

Frame it as goals, not hype:

- Modest goal, tight budget: semaglutide's ~15% is often more than enough, at the lower price. This is the value pick for most shoppers. - Higher goal or plateaued on semaglutide: tirzepatide's higher ceiling can justify the premium — especially where the spread over semaglutide is small. - Want the option to switch: pick a provider that flat-prices both molecules on one account, so you can step up without changing programs.

Don't let a teaser distort the comparison

Compare the ongoing flat prices, not intro rates. A tirzepatide that advertises a cheap first month and then triples can look competitive with semaglutide when it isn't. We break the pattern down in how to spot a GLP-1 teaser-rate trap. The honest comparison uses the month-twelve price for both.

Verify before you optimize

The cheapest tirzepatide is only a deal if it comes from a verified pharmacy. Compounded versions of both molecules sit outside the FDA-approval process, so pharmacy diligence matters — see is cheap compounded GLP-1 safe?. And if you have insurance, price the brand-name versions too in compounded vs brand-name GLP-1 before defaulting to cash.

The value verdict

For most cash-pay shoppers, semaglutide is the cheaper effective GLP-1 — enough effect, lower price. Tirzepatide earns its premium when your goal is higher or the price spread is thin. To see both molecules priced side by side from verified programs, start with our provider reviews and the compare tools, then pick the smallest price that reaches your goal.

If you're comparing the brand-name products specifically

Everything above is about the underlying molecules on cash-pay and compounded pricing. If you're insured and choosing between the actual FDA-approved brands, the calculation runs differently — see Wegovy vs Zepbound: what's actually different for the head-to-head trial data and how each brand's approved uses have diverged. And semaglutide and tirzepatide aren't the only two molecules in this class worth pricing out — the older, once-daily liraglutide is still a real option for some budgets; see semaglutide vs liraglutide: is the older, cheaper GLP-1 worth it?

This piece sits in our research index alongside every other sourced explainer we publish — the trials, the compounding rules and the pricing mechanics, grouped by the question each one answers.